An Open Label, Multicentre, Phase One Study Incorporating Early Application of CAR T cells for Primary Refractory Aggressive Lymphoma (2019–2025)
- Grant type:
- NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
- Researchers:
-
-
- Funded by:
- Commonwealth Department of Health and Aged Care
